INFU logo

INFUSYSTEM HOLDINGS INC

INFUNYSE AMERICAN
πŸ† #3536 by market capEarnings Nov 2 Β· PreUS Equity
$13.03β–² $0.16 (+1.24%)
πŸŒ™ After hours$13.03β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track INFU
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.2%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$263M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+2.5%
Slowing
πŸ“ŠGross Margin
57.5%
Healthy
πŸ’΅FCF Margin
9.4%
Moderate
βš–οΈP/S Ratio
1.8x
Cheap
Otter Score
64
Fair
No chart data available for INFU.

Trading Snapshot

Day Range
$12.92 – $13.09
52-Week Range
$7.29 – $13.20
Volume
$2.43B
Avg Volume
$2.82B
Shares Outstanding
20.2M
Next Earnings
Dec 12, 2026

Fundamentals Snapshot

Annual Revenue
$143M
Last Q Revenue
$37M
P/E Ratio
29.6
P/S Ratio
1.8x
EPS (TTM)
$0.41
Dividend Yield
β€”
Dilution (1yr)
βˆ’3.0%

Why Investors Own INFU

  • βœ“High-growth profile β€” revenue up +12.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 24% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INFU logo

INFUSYSTEM HOLDINGS INC

INFU
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$143Mβ–² +6.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
56.0%β–² +7.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$12Mβ–² +73.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$16Mβ–² +498.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
21.1Mβ–Ό βˆ’3.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$241Kβ–² +$28M YoY
StockOtter Β· stockotter.space

About INFUSYSTEM HOLDINGS INC

InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$14.73
β–² +13.1% Upside
High Target$16.41
Low Target$12.99
Based on 12 analysts

Latest News & Updates

Seeking AlphaΒ·5d ago

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

Defense WorldΒ·8d ago

Guardant Health (NASDAQ:GH) versus InfuSystem (NYSE:INFU) Critical Review

Guardant Health (NASDAQ: GH - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of

Business WireΒ·12d ago

InfuSystem to Host Investor Webcast on September 24, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Host Investor Webcast on SeptemberΒ 24, 2026.

Defense WorldΒ·13d ago

InfuSystem (NYSE:INFU) & Exagen (NASDAQ:XGN) Head to Head Contrast

Exagen (NASDAQ: XGN - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of

Defense WorldΒ·25d ago

BlackRock Inc. Takes Position in InfuSystem Holdings, Inc. $INFU

BlackRock Inc. bought a new position in shares of InfuSystem Holdings, Inc. (NYSE: INFU) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund

Seeking AlphaΒ·Aug 4

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript